Bioverativ(BIVV), a drug company focused on hemophilia and other blood disorders, was spun off by Biogen(BIIB) last week. Gabelli & Co initiated Bivoerativ stock as a buy with a value of $58, citing the company’s strong balance sheet(no debt, $325 million in cash), its limited exposure to Medicare, its potential to benefit from corporate tax reform, and its… Read More »
The drama surrounding Yahoo(YHOO)’s proposed spinoff of its Alibaba(BABA) stake continues. Though the company has said it is pushing forward and is optimistic, Barron’s reports that Morgan Stanley feels a 0% probability of the deal is priced in at the current stock price. The sentiment on the stock is now as if they’ll never make the spin happen,… Read More »
Telecom Itailia’s(TI) turbulent flirtation with the spin off of its fixed line assets took another shaky step forward as the company has engaged Morgan Stanley to advise on the process. Telecom Italia would be the first privatized European telecom to take such a step. Most likely the company would take outside investment in the fixed line assets and… Read More »
It’s the dog days of August and sports fans are in a frenzy. Has Tiger rebounded? Not this year. Exciting pennant races? Nope. What really has fans hopping and going wild is the start of NFL training camps. Really? Meaningless training camps? Yup and that fact is symbolic of the NFL’s power and outright dominance over the US… Read More »